These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32334948)

  • 1. Antifungal susceptibility testing practices in mycology laboratories in France, 2018.
    Bellanger AP; Persat F; Foulet F; Bonnal C; Accoceberry I; Angebault C; Angoulvant A; Augereau O; Bailly E; Bert F; Bonhomme J; Bouchara JP; Bougnoux ME; Bourdeau P; Bouteille B; Brun S; Brunet K; Camin-Ravenne AM; Cassaing S; Chouaki T; Cornet M; Costa D; Desbois N; Dorin J; Fekkar A; Fiacre A; Fréalle E; Gangneux JP; Guillot J; Guitard J; Hasseine L; Huguenin A; Lachaud L; Larréché S; Lavergne RA; Le Gal S; Le Govic Y; Letscher-Bru V; Machouart M; Mazars E; Nourrisson C; Paugam A; Ranque S; Risco-Castillo V; Sasso M; Sautour M; Sendid B; Senghor Y; Botterel F; Dannaoui E
    J Mycol Med; 2020 Jun; 30(2):100970. PubMed ID: 32334948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
    Cuenca-Estrella M; Arendrup MC; Chryssanthou E; Dannaoui E; Lass-Florl C; Sandven P; Velegraki A; Rodriguez-Tudela JL;
    Clin Microbiol Infect; 2007 Oct; 13(10):1018-22. PubMed ID: 17697001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal Susceptibility Testing: Current Approaches.
    Berkow EL; Lockhart SR; Ostrosky-Zeichner L
    Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32349998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality assurance for antimicrobial susceptibility testing of
    Sawatzky P; Martin I; Galarza P; Carvallo MET; Araya Rodriguez P; Cruz OMS; Hernandez AL; Martinez MF; Borthagaray G; Payares D; Moreno JE; Chiappe M; Corredor AH; Thakur SD; Dillon JR
    Sex Transm Infect; 2018 Nov; 94(7):479-482. PubMed ID: 29674407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro.
    Cuenca-Estrella M; Rodriguez-Tudela JL
    Expert Rev Anti Infect Ther; 2010 Mar; 8(3):267-76. PubMed ID: 20192681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of laboratory practices for diagnosis of fungal infection in seven Asian countries: An Asia Fungal Working Group (AFWG) initiative.
    Chindamporn A; Chakrabarti A; Li R; Sun PL; Tan BH; Chua M; Wahyuningsih R; Patel A; Liu Z; Chen YC; Chayakulkeeree M
    Med Mycol; 2018 Jun; 56(4):416-425. PubMed ID: 29036605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National mycology laboratory diagnostic capacity for invasive fungal diseases in 2017: Evidence of sub-optimal practice.
    Schelenz S; Owens K; Guy R; Rautemaa-Richardson R; Manuel RJ; Richardson M; Moore C; Enoch DA; Micallef C; Howard P; Agrawal SG; Johnson EM; Muller-Pebody B;
    J Infect; 2019 Aug; 79(2):167-173. PubMed ID: 31233810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determining the susceptibility of microfungi to antifungals and interpreting the results].
    Mallátová N
    Klin Mikrobiol Infekc Lek; 2007 Aug; 13(4):150-5. PubMed ID: 17929220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentre study to determine the Etest epidemiological cut-off values of antifungal drugs in Candida spp. and Aspergillus fumigatus species complex.
    Salsé M; Gangneux JP; Cassaing S; Delhaes L; Fekkar A; Dupont D; Botterel F; Costa D; Bourgeois N; Bouteille B; Houzé S; Dannaoui E; Guegan H; Charpentier E; Persat F; Favennec L; Lachaud L; Sasso M
    Clin Microbiol Infect; 2019 Dec; 25(12):1546-1552. PubMed ID: 31082487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility testing by Australian veterinary diagnostic laboratories.
    Hardefeldt LY; Marenda M; Crabb H; Stevenson MA; Gilkerson JR; Billman-Jacobe H; Browning GF
    Aust Vet J; 2018 Apr; 96(4):142-146. PubMed ID: 29577253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A national survey on fungal infection diagnostic capacity in the clinical mycology laboratories of tertiary care hospitals in China.
    Wang H; Wang Y; Yang QW; Ni YX; Lin LK; Luo YP; Sun ZY; Li M; Wu WJ; Zhang QQ; Su DH; Yu H; Kang M; Xu HP; Liu W; Yang Q; Jian C; Guo LN; Yang WH; Xiao M; Hsueh PR; Xu YC
    J Microbiol Immunol Infect; 2020 Dec; 53(6):845-853. PubMed ID: 32334978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents.
    Arendrup MC; Meletiadis J; Mouton JW; Guinea J; Cuenca-Estrella M; Lagrou K; Howard SJ;
    Clin Microbiol Infect; 2016 Jun; 22(6):571.e1-4. PubMed ID: 26851656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten years of external quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in Europe elucidate high reliability of data.
    Cole MJ; Quaye N; Jacobsson S; Day M; Fagan E; Ison C; Pitt R; Seaton S; Woodford N; Stary A; Pleininger S; Crucitti T; Hunjak B; Maikanti P; Hoffmann S; Viktorova J; Buder S; Kohl P; Tzelepi E; Siatravani E; Balla E; Hauksdóttir GS; Rose L; Stefanelli P; Carannante A; Pakarna G; Mifsud F; Cassar RZ; Linde I; Bergheim T; Steinbakk M; Mlynarczyk-Bonikowska B; Borrego MJ; Shepherd J; Pavlik P; Jeverica S; Vazquez J; Abad R; Weiss S; Spiteri G; Unemo M
    BMC Infect Dis; 2019 Mar; 19(1):281. PubMed ID: 30909883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility-testing in Aspergillus species.
    Lass-Flörl C; Perkhofer S
    Mycoses; 2008 Sep; 51(5):437-46. PubMed ID: 18422914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Etest and disk diffusion methods compared with broth microdilution antifungal susceptibility testing of clinical isolates of Candida spp. against posaconazole.
    Diekema DJ; Messer SA; Hollis RJ; Boyken LB; Tendolkar S; Kroeger J; Pfaller MA
    J Clin Microbiol; 2007 Jun; 45(6):1974-7. PubMed ID: 17301284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antifungal susceptibility testing method for dermatophytes -determination of MIC and MFC values].
    Koga H
    Med Mycol J; 2014; 55(2):J57-63. PubMed ID: 24943208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal susceptibility testing: technical advances and potential clinical applications.
    Pfaller MA; Rex JH; Rinaldi MG
    Clin Infect Dis; 1997 May; 24(5):776-84. PubMed ID: 9142769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of results of fluconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program.
    Pfaller MA; Hazen KC; Messer SA; Boyken L; Tendolkar S; Hollis RJ; Diekema DJ
    J Clin Microbiol; 2004 Aug; 42(8):3607-12. PubMed ID: 15297505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ability of laboratories to detect emerging antimicrobial resistance: proficiency testing and quality control results from the World Health Organization's external quality assurance system for antimicrobial susceptibility testing.
    Tenover FC; Mohammed MJ; Stelling J; O'Brien T; Williams R
    J Clin Microbiol; 2001 Jan; 39(1):241-50. PubMed ID: 11136778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.